Collin, C.; Davies, P.; Mutiboko, I.K.; Ratcliffe, S.; Sativex Spasticity in MS Study Group (2007). «Randomised controlled trial of cannabis based medicine in spasticity caused by Multiple Sclerosis». European Journal of Neurology(en inglés)14 (3): 290-296. ISSN1468-1331. PMID17355549. doi:10.1111/j.1468-1331.2006.01639.x.
Wade, D.; Makela, P.; Robson, P.; House, H.; Bateman, C. (2004). «Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients». Multiple Sclerosis Journal(en inglés)10 (4): 434-41. ISSN1352-4585. PMID15327042. doi:10.1191/1352458504ms1082oa.
Wade, D.; Makela, P.; House, H.; Bateman, C.; Robson, P. (2006). «Long-term use of a cannabis-based medicine in the treatment of spasticity and other symptoms in multiple sclerosis». Multiple Sclerosis Journal(en inglés)12 (5): 639-45. ISSN1352-4585. PMID17086911. doi:10.1177/1352458505070618.
Wade, D.; Robson, P.; House, H.; Makela, P.; Aram, J. (2003). «A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms». Clinical Rehabilitation(en inglés)17 (1): 21-9. ISSN0269-2155. PMID12617376. doi:10.1191/0269215503cr581oa.
drugdevelopment-technology.com
[1] Sativex - Investigational Cannabis-Based Treatment for Pain nd Multiple Sclerosis Drug Development Technology
issn.org
portal.issn.org
Collin, C.; Davies, P.; Mutiboko, I.K.; Ratcliffe, S.; Sativex Spasticity in MS Study Group (2007). «Randomised controlled trial of cannabis based medicine in spasticity caused by Multiple Sclerosis». European Journal of Neurology(en inglés)14 (3): 290-296. ISSN1468-1331. PMID17355549. doi:10.1111/j.1468-1331.2006.01639.x.
Wade, D.; Makela, P.; Robson, P.; House, H.; Bateman, C. (2004). «Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients». Multiple Sclerosis Journal(en inglés)10 (4): 434-41. ISSN1352-4585. PMID15327042. doi:10.1191/1352458504ms1082oa.
Wade, D.; Makela, P.; House, H.; Bateman, C.; Robson, P. (2006). «Long-term use of a cannabis-based medicine in the treatment of spasticity and other symptoms in multiple sclerosis». Multiple Sclerosis Journal(en inglés)12 (5): 639-45. ISSN1352-4585. PMID17086911. doi:10.1177/1352458505070618.
Wade, D.; Robson, P.; House, H.; Makela, P.; Aram, J. (2003). «A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms». Clinical Rehabilitation(en inglés)17 (1): 21-9. ISSN0269-2155. PMID12617376. doi:10.1191/0269215503cr581oa.
nih.gov
ncbi.nlm.nih.gov
Collin, C.; Davies, P.; Mutiboko, I.K.; Ratcliffe, S.; Sativex Spasticity in MS Study Group (2007). «Randomised controlled trial of cannabis based medicine in spasticity caused by Multiple Sclerosis». European Journal of Neurology(en inglés)14 (3): 290-296. ISSN1468-1331. PMID17355549. doi:10.1111/j.1468-1331.2006.01639.x.
Wade, D.; Makela, P.; Robson, P.; House, H.; Bateman, C. (2004). «Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients». Multiple Sclerosis Journal(en inglés)10 (4): 434-41. ISSN1352-4585. PMID15327042. doi:10.1191/1352458504ms1082oa.
Wade, D.; Makela, P.; House, H.; Bateman, C.; Robson, P. (2006). «Long-term use of a cannabis-based medicine in the treatment of spasticity and other symptoms in multiple sclerosis». Multiple Sclerosis Journal(en inglés)12 (5): 639-45. ISSN1352-4585. PMID17086911. doi:10.1177/1352458505070618.
Wade, D.; Robson, P.; House, H.; Makela, P.; Aram, J. (2003). «A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms». Clinical Rehabilitation(en inglés)17 (1): 21-9. ISSN0269-2155. PMID12617376. doi:10.1191/0269215503cr581oa.